NCT00930943View on ClinicalTrials.gov

Effect of Extended-release Oxymorphone Taken With or Without Food on Cognitive Functioning

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
Chronic Pain
Interventions
DRUG

Oxymorphone ER

40 mg qd twice

Trial Locations (1)

02481

MedVadis Research Corporation, Wellesley Hills

Sponsors
All Listed Sponsors
lead

MedVadis Research Corporation

INDUSTRY

NCT00930943 - Effect of Extended-release Oxymorphone Taken With or Without Food on Cognitive Functioning | Biotech Hunter | Biotech Hunter